Publications
Specialty
Search
Wound Care
07/23/2024
StimLabs announced enrollment of the first patient in the CAMPSTIM multi-center RCT that aims to demonstrate the clinical outcomes of at least four of StimLabs' placental-based tissue products with standard of care (SOC) vs SOC alone in patients with hard-to-heal DFUs.
Wound Care
07/23/2024
Kerecis announced it has received approval from Palmetto GBA for the Kerecis Shield used in private doctor clinics. The approval means that 4 of the 7 insurance companies administering Medicare plans across the US have set a fee schedule for the Shield product line.
Wound Care
07/23/2024
IR-MED received a $500,000 grant from the Israel Innovation Authority to develop its platform technology for early detection of DFUs. DiaSafe is being developed to provide safe, real-time optical readings of biomarkers to detect the early signs of DFUs with accuracy. Bus Insider
Wound Care
07/23/2024
MediWound announced it has entered into a $25.0MM definitive share purchase agreement with several new and existing investors, including $15.0MM from Mölnlycke Health Care. The proceeds will fund advancing EscharEx pre-commercial activities and increasing manufacturing capacity.
Wound Care
07/23/2024
CMS released the Q224 Drug and Biologicals Final Quarterly Coding Decisions and added 12 new Q codes, including multiple new codes for Tides Medical's Artacent products, another new code for Merakris Therapeutics' Dermacyte and some newer players to wound care.
Wound Care
07/23/2024
A 149-patient study evaluated the use and performance of Biatain Fiber dressing in the management of wounds in community nursing practice. The study found patients who received treatment with the gelling fibers experienced improvements in the condition of a range of complex wounds.
Wound Care
07/23/2024
IART announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, MA. The new facility should be operational in H126 and will provide the flexibility to implement more effective quality systems and efficient process flows.
Oncology
07/23/2024
According to results from a phase 2 trial, brentuximab vedotin and ibrutinib therapy demonstrated activity among patients with R/R Hodgkin lymphoma, however the combination cannot be recommended for future therapeutic development due to significant toxicity.
Oncology
07/23/2024
Jason Westin, MD, shares expert insight regarding CAR T-cell therapy as standard of care treatment for patients with early relapsed large B-cell lymphoma at the 2024 Pan Pacific Lymphoma Conference.
Wound Care
07/23/2024
Microbion was granted US Patent “Bismuth-thiol Compositions And Methods For Treating Wounds“ describing bismuth-thiol compounds and pharmaceutical preparations for topical treatment of DFU infections. 12036200
First Report Managed Care
07/23/2024
True or False: Patients with chronic obstructive pulmonary disease (COPD) have a lower incidence of RSV infection compared to the general population because treatments for COPD also alleviate the symptoms of RSV.
Psych Congress Network
07/23/2024
The US Food and Drug Administration (FDA) has again declined Swedish drug manufacturer Orexo’s New Drug Application (NDA) for OX125, a high-dose naloxone nasal spray for opioid overdose reversal.
Journal of Clinical Pathways
07/23/2024
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
APP Institute Oncology
07/23/2024
This animation explains the role of BCMA in the life cycle of plasma cells and the effects of overexpression of BCMA on the abnormal survival of these cells.
APP Institute Oncology
07/23/2024
This animation discusses the role of BCL2 in normal cell function and explains the effects of disruptions in the BCL2 gene on cell signaling.
APP Institute Oncology
07/23/2024
This animation explains the role of the ALK oncogene in normal cellular functioning and the effect of an abnormal translocation event where ALK fuses to another gene.
APP Institute Oncology
07/23/2024
This animation explains the role of the 20S proteasome in regulating the cellular life cycle and the effects of disruptions in the ubiquitin proteasome system.
Neurology
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
Journal of Clinical Pathways
07/23/2024
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Pharmacy Learning Network
07/23/2024
True or False: Georgia State University researchers have developed reporter structures that emit light when potential antiviral agents inhibit RSV genes in cells used for drug screening assays.